New Approvals, Production Delays and Lab Studies Influence Vaccine Media Coverage

Vaccine programs are in full swing across the U.S. and much of Western Europe. But with new vaccines receiving approval from regulatory bodies and testing being done on each vaccine’s strength against rising Covid variants, their media coverage is fluctuating quickly.

By |2021-04-13T03:42:10-05:00March 10th, 2021|Categories: Blog, Economy, S4D Insight|